FOXO Technologies Inc. (FOXO)
FOXO Technologies Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in West Palm Beach, FL, US. The stock last traded at $0.07, down 7.14% on the session, giving a market capitalisation of $649,751. On trailing twelve-month figures it carries a trailing P/E of -0.09, a net margin of -72.2%. Its beta of 2.37 implies it has historically moved more than the broad market.
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.
FOXO Technologies Inc. is most often compared with the following Healthcare names: